Afya Limited (NASDAQ:AFYA – Get Free Report) has received a consensus rating of “Hold” from the eight analysts that are covering the company, MarketBeat.com reports. Seven equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $17.20.
Several analysts have issued reports on AFYA shares. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Afya in a research note on Monday, April 20th. Bank of America reissued a “neutral” rating on shares of Afya in a research note on Thursday, June 11th. Wall Street Zen lowered Afya from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 2nd. JPMorgan Chase & Co. dropped their price objective on Afya from $22.00 to $21.50 and set a “neutral” rating for the company in a research note on Thursday, April 30th. Finally, Zacks Research lowered Afya from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, May 6th.
Read Our Latest Stock Report on AFYA
Afya Price Performance
Insider Activity
In other news, CFO Luis Andre Carpintero Blanco sold 10,000 shares of the stock in a transaction that occurred on Wednesday, April 8th. The stock was sold at an average price of $15.20, for a total transaction of $152,000.00. Following the completion of the sale, the chief financial officer owned 51,103 shares of the company’s stock, valued at approximately $776,765.60. This represents a 16.37% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Virgilio Deloy Capobian Gibbon sold 20,900 shares of the stock in a transaction that occurred on Thursday, April 2nd. The shares were sold at an average price of $14.94, for a total value of $312,246.00. Following the sale, the chief executive officer directly owned 109,218 shares of the company’s stock, valued at approximately $1,631,716.92. This trade represents a 16.06% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 123,547 shares of company stock valued at $1,854,920. Corporate insiders own 0.80% of the company’s stock.
Institutional Trading of Afya
A number of institutional investors have recently made changes to their positions in the stock. Daiwa Securities Group Inc. bought a new position in shares of Afya during the fourth quarter valued at approximately $43,000. Militia Capital Partners LP bought a new position in shares of Afya during the second quarter valued at approximately $71,000. Quantbot Technologies LP bought a new position in shares of Afya during the second quarter valued at approximately $117,000. Van ECK Associates Corp raised its holdings in shares of Afya by 15.7% during the third quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock valued at $159,000 after acquiring an additional 1,377 shares in the last quarter. Finally, State of Wyoming bought a new position in shares of Afya during the second quarter valued at approximately $164,000. Hedge funds and other institutional investors own 88.02% of the company’s stock.
About Afya
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
See Also
- Five stocks we like better than Afya
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
